Search Result

Search Result

Results for "

AG-120

" in MCE Product Catalog:

By Targets:	Isocitrate Dehydrogenase (IDH) (2)
By Research Areas:	Cancer (2) Metabolic Disease (1)

Cat. No.	Product Name	Target	Research Areas

Ivosidenib AG-120	Isocitrate Dehydrogenase (IDH)	Cancer Metabolic Disease
Ivosidenib (AG-120) is an orally active inhibitor of isocitrate dehydrogenase 1 mutant (mIDH1) enzyme, it exhibits profound d-2-hydroxyglutatrate (2-HG) lowering in vivo. Ivosidenib (AG-120) has the potential for AML therapy due to its acceptable safety profile and clinical activity.

HY-18767A

(R,S)-Ivosidenib
(R,S)-AG-120
Isocitrate Dehydrogenase (IDH) Cancer

(R,S)-Ivosidenib ((R,S)-AG-120) is the less active enantiomer of Ivosidenib (AG-120).

MCE Magic Cece

MedChemExpress: Contact Us; About Us; Headquarters; Distributors; Statement on False Report; Careers

Customer Support: Technical Support; Service; Ordering Information; Easy Return; Shipping Rates & Policies; Intellectual Property Promise

Resources: Free Sample; Resources; Molarity Calculator; Dilution Calculator; Terms & Conditions; Reconstitution Calculator; Specific Activity Calculator

Subscribe to our E-newsletter

Products are chemical reagents for research use only and are not intended for human use. We do not sell to patients.

Copyright © 2013-2023 MedChemExpress. All Rights Reserved.: Site Map Privacy Policy

Join with us